{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:03Z","timestamp":1786980483615,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["NMRPG8G6182"],"award-info":[{"award-number":["NMRPG8G6182"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8E1671"],"award-info":[{"award-number":["CMRPG8E1671"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8G0272"],"award-info":[{"award-number":["CMRPG8G0272"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The early detection of psoriatic arthritis (PSA) poses a challenge to rheumatologists, even when their diagnosis is aided by sonography. In order to facilitate early detection of PSA among patients with psoriasis (PSO), we retrospectively analyzed of the relationships between serological markers and comorbidities in 629 psoriatic patients, 102 of which had PSA, while the other 527 had PSO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serological markers were found not to be useful in distinguishing between PSA and PSO (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&gt;\u20090.05 for all comparisons). The prevalence rate of PSA among PSO patients was around 19.4%. Two components of metabolic syndrome\u2014hyperlipidemia (2.94%) and gout (4.9%)\u2014were significantly more prevalent in PSA patients than in PSO patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.05). The odds ratio for PSA is 15.94 in patients with hyperlipidemia with a 95% confidence interval (CI) of 1.64\u2013154.80; meanwhile, the odds ratio for PSA is 3.83 in patients with gout with a 95% CI of 1.19\u201312.31. Allergic rhinitis (5.88%) was more prevalent in PSA patients than in PSO patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.01). The odds ratio was 8.17 in patients with allergic rhinitis with a 95% CI of 2.26\u201329.50. Plasma hs-miR-210-3p distinguishes PSA from PSO, and its levels can also be distinguished from PSA after treated with anti-TNF\u03b1 biologics agents (both\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      No clinical available serology markers, but hyperlipidemia, gout, axial spondylopathy (inflammatory back pain), or allergic rhinitis, could differentiate between psoriatic arthritis from psoriasis. Plasma hs-miR-210-3p and comorbidities may differentiate psoriatic arthritis from psoriasis.\n                      <jats:table-wrap>\n                        <jats:table>\n                          <jats:tbody>\n                            <jats:tr>\n                              <jats:td colspan=\"2\">\n                                <jats:bold>Key Points<\/jats:bold>\n                                <jats:italic>\u2022 Clinical manifestations and comorbidities are different between psoriatic arthritis and psoriasis only patients.<\/jats:italic>\n                                <jats:italic>\u2022 Traditional serology markers are similar between psoriatic arthritis and psoriasis-only patients.<\/jats:italic>\n                                <jats:italic>\u2022 Plasma hs-miR-210-3p distinguishes PSA from PSO, and its levels can also be distinguished from PSA after treated with anti-TNF\u03b1 biologics agents in our study.<\/jats:italic>\n                              <\/jats:td>\n                            <\/jats:tr>\n                          <\/jats:tbody>\n                        <\/jats:table>\n                      <\/jats:table-wrap>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10067-020-05132-1","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T06:02:57Z","timestamp":1590645777000},"page":"3677-3684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7274-3458","authenticated-orcid":false,"given":"Yu-Jih","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"issue":"11","key":"5132_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrrheum.2009.210","volume":"5","author":"AP Anandarajah","year":"2009","unstructured":"Anandarajah AP, Ritchlin CT (2009) The diagnosis and treatment of early psoriatic arthritis. Nat Rev Rheumatol 5(11):634\u2013641. https:\/\/doi.org\/10.1038\/nrrheum.2009.210","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"5132_CR2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3899\/jrheum.130949","volume":"41","author":"L Eder","year":"2014","unstructured":"Eder L, Jayakar J, Thavaneswaran A, Haddad A, Chandran V, Salonen D, Rosen CF, Gladman DD (2014) Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? J Rheumatol 41(3):466\u2013472. https:\/\/doi.org\/10.3899\/jrheum.130949","journal-title":"J Rheumatol"},{"issue":"1","key":"5132_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2310\/7750.2014.13151","volume":"19","author":"W Gulliver","year":"2015","unstructured":"Gulliver W, Lynde C, Dutz JP, Vender RB, Yeung J, Bourcier M, Dion PL, Hong CH, Searles G, Poulin Y (2015) Think beyond the skin: 2014 Canadian expert opinion paper on treating to target in plaque psoriasis. J Cutan Med Surg 19(1):22\u201327. https:\/\/doi.org\/10.2310\/7750.2014.13151","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"5132_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, Kavanaugh A, Kvien TK, Landewe R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Schoels M, Sieper J, Wit M, Baraliakos X, Betteridge N, Burgos-Vargas R, Collantes-Estevez E, Deodhar A, Elewaut D, Gossec L, Jongkees M, Maccarone M, Redlich K, van den Bosch F, Wei JC, Winthrop K, van der Heijde D (2014) Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 73(1):6\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203419","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5132_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/annrheumdis-2013-203860","volume":"73","author":"MM Schoels","year":"2014","unstructured":"Schoels MM, Braun J, Dougados M, Emery P, Fitzgerald O, Kavanaugh A, Kvien TK, Landewe R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Sieper J, Smolen JS, Wit M, van der Heijde D (2014) Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis 73(1):238\u2013242. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203860","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5132_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10067-013-2412-2","volume":"33","author":"H Maldonado Ficco","year":"2014","unstructured":"Maldonado Ficco H, Citera G, Maldonado Cocco JA (2014) Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria. Clin Rheumatol 33(2):243\u2013246. https:\/\/doi.org\/10.1007\/s10067-013-2412-2","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5132_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.2009.09281.x","volume":"161","author":"AB Alexandroff","year":"2009","unstructured":"Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ (2009) More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 161(1):1\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09281.x","journal-title":"Br J Dermatol"},{"key":"5132_CR8","doi-asserted-by":"publisher","first-page":"474028","DOI":"10.1155\/2013\/474028","volume":"2013","author":"S Dalmady","year":"2013","unstructured":"Dalmady S, Kiss M, Kepiro L, Kovacs L, Sonkodi G, Kemeny L, Gyulai R (2013) Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris. Clin Dev Immunol 2013:474028\u2013474029. https:\/\/doi.org\/10.1155\/2013\/474028","journal-title":"Clin Dev Immunol"},{"issue":"30\u201331","key":"5132_CR9","first-page":"A2636","volume":"155","author":"K Mosterd","year":"2011","unstructured":"Mosterd K, Kapinga TH, Martens H, van Mierlo PL, Schoonbrood TH, Poblete-Gutierrez P (2011) Psoriasiform disorders with joint symptoms. Ned Tijdschr Geneeskd 155(30\u201331):A2636","journal-title":"Ned Tijdschr Geneeskd"},{"key":"5132_CR10","doi-asserted-by":"publisher","first-page":"812781","DOI":"10.1155\/2013\/812781","volume":"2013","author":"SS Wei","year":"2013","unstructured":"Wei SS, Sinniah R (2013) Adalimumab (TNF alpha inhibitor) therapy exacerbates IgA glomerulonephritis acute renal injury and induces lupus autoantibodies in a psoriasis patient. Case Rep Nephrol 2013:812781\u2013812784. https:\/\/doi.org\/10.1155\/2013\/812781","journal-title":"Case Rep Nephrol"},{"issue":"4","key":"5132_CR11","first-page":"273","volume":"3","author":"S Rose","year":"2013","unstructured":"Rose S, Sheth NH, Baker JF, Ogdie A, Raper A, Saboury B, Werner TJ, Thomas P, Vanvoorhees A, Alavi A, Torigian DA, Gelfand JM, Mehta NN (2013) A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET\/CT: a pilot study. Am J Cardiovasc Dis 3(4):273\u2013278","journal-title":"Am J Cardiovasc Dis"},{"issue":"2","key":"5132_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jaad.2007.02.007","volume":"57","author":"HM Kremers","year":"2007","unstructured":"Kremers HM, McEvoy MT, Dann FJ, Gabriel SE (2007) Heart disease in psoriasis. J Am Acad Dermatol 57(2):347\u2013354. https:\/\/doi.org\/10.1016\/j.jaad.2007.02.007","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"5132_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jaad.2008.12.031","volume":"60","author":"RV Patel","year":"2009","unstructured":"Patel RV, Clark LN, Lebwohl M, Weinberg JM (2009) Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol 60(6):1001\u20131017. https:\/\/doi.org\/10.1016\/j.jaad.2008.12.031","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"5132_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jdermsci.2011.03.002","volume":"63","author":"TF Tsai","year":"2011","unstructured":"Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, Tang CH (2011) Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci 63(1):40\u201346. https:\/\/doi.org\/10.1016\/j.jdermsci.2011.03.002","journal-title":"J Dermatol Sci"},{"key":"5132_CR15","first-page":"270","volume":"87","author":"S Sehgal","year":"1988","unstructured":"Sehgal S, Kumar B, Kaur S, Datta U, Anand S (1988) Antibodies to extractable nuclear antigens in psoriasis vulgaris. Indian J Med Res 87:270\u2013274","journal-title":"Indian J Med Res"},{"key":"5132_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2015.08.004","volume":"80","author":"CM Nguyen","year":"2015","unstructured":"Nguyen CM, Liao W (2015) Genomic imprinting in psoriasis and atopic dermatitis: a review. J Dermatol Sci 80:89\u201393. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.08.004","journal-title":"J Dermatol Sci"},{"issue":"9","key":"5132_CR17","first-page":"342","volume":"8","author":"J Frankl","year":"1950","unstructured":"Frankl J, Koranyi B (1950) Psoriasis and pyoderma. Z Haut Geschlechtskr 8(9):342\u2013347","journal-title":"Z Haut Geschlechtskr"},{"issue":"2","key":"5132_CR18","first-page":"233","volume":"68","author":"LP Barker","year":"1953","unstructured":"Barker LP (1953) Case for diagnosis: pyoderma; onychomycosis; psoriasis. AMA Arch Derm Syphilol 68(2):233\u2013234","journal-title":"AMA Arch Derm Syphilol"},{"key":"5132_CR19","doi-asserted-by":"publisher","first-page":"792968","DOI":"10.1155\/2015\/792968","volume":"2015","author":"A Schwandt","year":"2015","unstructured":"Schwandt A, Bergis D, Dapp A, Ebner S, Jehle PM, Koppen S, Risse A, Zimny S, Holl RW (2015) Psoriasis and diabetes: a multicenter study in 222078 type 2 diabetes patients reveals high levels of depression. J Diabetes Res 2015:792968\u2013792910. https:\/\/doi.org\/10.1155\/2015\/792968","journal-title":"J Diabetes Res"},{"issue":"4","key":"5132_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jaad.2013.11.023","volume":"70","author":"MS Lee","year":"2014","unstructured":"Lee MS, Lin RY, Lai MS (2014) Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. J Am Acad Dermatol 70(4):691\u2013698. https:\/\/doi.org\/10.1016\/j.jaad.2013.11.023","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"5132_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archdermatol.2009.48","volume":"145","author":"AA Qureshi","year":"2009","unstructured":"Qureshi AA, Choi HK, Setty AR, Curhan GC (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 145(4):379\u2013382. https:\/\/doi.org\/10.1001\/archdermatol.2009.48","journal-title":"Arch Dermatol"},{"issue":"5","key":"5132_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/apt.13075","volume":"41","author":"EC Verna","year":"2015","unstructured":"Verna EC, Loomba R (2015) Editorial: call to screen for NAFLD and NASH in psoriasis. Aliment Pharmacol Ther 41(5):492\u2013493. https:\/\/doi.org\/10.1111\/apt.13075","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"5132_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/apt.13042","volume":"41","author":"KK Roberts","year":"2015","unstructured":"Roberts KK, Cochet AE, Lamb PB, Brown PJ, Battafarano DF, Brunt EM, Harrison SA (2015) The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic. Aliment Pharmacol Ther 41(3):293\u2013300. https:\/\/doi.org\/10.1111\/apt.13042","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"5132_CR24","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/annrheumdis-2014-205212","volume":"74","author":"JF Merola","year":"2015","unstructured":"Merola JF, Wu S, Han J, Choi HK, Qureshi AA (2015) Psoriasis, psoriatic arthritis and risk of gout in US men and women. Ann Rheum Dis 74(8):1495\u20131500. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205212","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5132_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5604\/15093492.1119622","volume":"16","author":"P Morasiewicz","year":"2014","unstructured":"Morasiewicz P, Koprowski P, Dragan S (2014) Coexisting psoriasis, psoriatic arthritis, gout and Dupuytren\u2019s contracture. Ortop Traumatol Rehabil 16(4):441\u2013447. https:\/\/doi.org\/10.5604\/15093492.1119622","journal-title":"Ortop Traumatol Rehabil"},{"issue":"6","key":"5132_CR26","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/annrheumdis-2012-202922","volume":"72","author":"P Machado","year":"2013","unstructured":"Machado P, Landewe R, Braun J, Baraliakos X, Hermann KG, Hsu B, Baker D, van der Heijde D (2013) Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype. Ann Rheum Dis 72(6):1104\u20131107. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202922","journal-title":"Ann Rheum Dis"},{"issue":"3\u20134","key":"5132_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ajg.2014.08.001","volume":"15","author":"EA Taha","year":"2014","unstructured":"Taha EA, Mekky MA, Morsy H, Saleh MA, Nafeh HM, Ez-Aldin AM, Sayed SK (2014) Study of the impact of viral load of hepatitis C on patients with concomitant psoriasis vulgaris. Arab J Gastroenterol 15(3\u20134):98\u2013102. https:\/\/doi.org\/10.1016\/j.ajg.2014.08.001","journal-title":"Arab J Gastroenterol"},{"issue":"12","key":"5132_CR28","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/j.1468-3083.2011.04360.x","volume":"26","author":"V Brazzelli","year":"2012","unstructured":"Brazzelli V, Carugno A, Alborghetti A, Cananzi R, Sangiovanni L, Barbarini G, De Silvestri A, Borroni RG (2012) Hepatitis C infection in Italian psoriatic patients: prevalence and correlation with patient age and psoriasis severity. J Eur Acad Dermatol Venereol 26(12):1581\u20131582. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04360.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"5132_CR29","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","volume":"56","author":"JA Weber","year":"2010","unstructured":"Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56(11):1733\u20131741. https:\/\/doi.org\/10.1373\/clinchem.2010.147405","journal-title":"Clin Chem"},{"issue":"6","key":"5132_CR30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O (2015) Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74(6):1045\u20131050. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204858","journal-title":"Ann Rheum Dis"},{"key":"5132_CR31","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1111\/jdv.13210","volume":"29","author":"L Spelman","year":"2015","unstructured":"Spelman L, Su JC, Fernandez-Penas P, Varigos GA, Cooper AJ, Baker CS, Lee M, Ring JM, Thirunavukkarasu K (2015) Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice. J Eur Acad Dermatol Venereol 29:2184\u20132191. https:\/\/doi.org\/10.1111\/jdv.13210","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5132_CR32","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/1756-185X.12580","volume":"18","author":"K Nas","year":"2015","unstructured":"Nas K, Karkucak M, Durmus B, Karatay S, Capkin E, Kaya A, Ucmak D, Akar ZA, Cevik R, Kilic E, Kilic G, Ozgocmen S (2015) Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis. Int J Rheum Dis 18:873\u2013879. https:\/\/doi.org\/10.1111\/1756-185X.12580","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"5132_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3899\/jrheum.111244","volume":"39","author":"SP Raychaudhuri","year":"2012","unstructured":"Raychaudhuri SP (2012) Comorbidities of psoriatic arthritis -- metabolic syndrome and prevention: a report from the GRAPPA 2010 annual meeting. J Rheumatol 39(2):437\u2013440. https:\/\/doi.org\/10.3899\/jrheum.111244","journal-title":"J Rheumatol"},{"issue":"5","key":"5132_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/jdv.12742","volume":"29","author":"E Edson-Heredia","year":"2015","unstructured":"Edson-Heredia E, Zhu B, Lefevre C, Wang M, Barrett A, Bushe CJ, Cox A, Wu JJ, Maeda-Chubachi T (2015) Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. J Eur Acad Dermatol Venereol 29(5):955\u2013963. https:\/\/doi.org\/10.1111\/jdv.12742","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"5132_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/jdv.12847","volume":"29","author":"R Candia","year":"2015","unstructured":"Candia R, Ruiz A, Torres-Robles R, Chavez-Tapia N, Mendez-Sanchez N, Arrese M (2015) Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 29(4):656\u2013662. https:\/\/doi.org\/10.1111\/jdv.12847","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"5132_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jdermsci.2004.08.012","volume":"36","author":"M Ito","year":"2004","unstructured":"Ito M, Ogawa K, Takeuchi K, Nakada A, Heishi M, Suto H, Mitsuishi K, Sugita Y, Ogawa H, Ra C (2004) Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis. J Dermatol Sci 36(3):157\u2013164. https:\/\/doi.org\/10.1016\/j.jdermsci.2004.08.012","journal-title":"J Dermatol Sci"},{"key":"5132_CR37","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/art.39649","volume":"68","author":"F Ciccia","year":"2016","unstructured":"Ciccia F, Guggino G, Ferrante A, Raimondo S, Bignone R, Rodolico V, Peralta S, Van Tok M, Cannizzaro A, Schinocca C, Ruscitti P, Cipriani P, Giacomelli R, Alessandro R, Dieli F, Rizzo A, Baeten D, Triolo G (2016) IL-9 over-expression and Th9 polarization characterize the inflamed gut, the synovial tissue and the peripheral blood of patients with psoriatic arthritis. Arthritis Rheum 68:1922\u20131931. https:\/\/doi.org\/10.1002\/art.39649","journal-title":"Arthritis Rheum"},{"issue":"31","key":"5132_CR38","doi-asserted-by":"publisher","first-page":"eaat5943","DOI":"10.1126\/sciimmunol.aat5943","volume":"4","author":"C Micosse","year":"2019","unstructured":"Micosse C, von Meyenn L, Steck O, Kipfer E, Adam C, Simillion C, Seyed Jafari SM, Olah P, Yawlkar N, Simon D, Borradori L, Kuchen S, Yerly D, Homey B, Conrad C, Snijder B, Schmidt M, Schlapbach C (2019) Human \"TH9\" cells are a subpopulation of PPAR-gamma(+) TH2 cells. Sci Immunol 4(31):eaat5943. https:\/\/doi.org\/10.1126\/sciimmunol.aat5943","journal-title":"Sci Immunol"},{"key":"5132_CR39","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3389\/fimmu.2018.01118","volume":"9","author":"T Li","year":"2018","unstructured":"Li T, Rong HM, Zhang C, Zhai K, Tong ZH (2018) IL-9 deficiency promotes pulmonary Th17 response in murine model of pneumocystis infection. Front Immunol 9:1118. https:\/\/doi.org\/10.3389\/fimmu.2018.01118","journal-title":"Front Immunol"},{"issue":"6","key":"5132_CR40","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","volume":"15","author":"MM Fort","year":"2001","unstructured":"Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, Muchamuel T, Hurst SD, Zurawski G, Leach MW, Gorman DM, Rennick DM (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15(6):985\u2013995","journal-title":"Immunity"},{"issue":"1","key":"5132_CR41","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/ar2915","volume":"12","author":"YG Chiu","year":"2010","unstructured":"Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT (2010) CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther 12(1):R14. https:\/\/doi.org\/10.1186\/ar2915","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"5132_CR42","first-page":"2","volume":"18","author":"YH Chiu","year":"2012","unstructured":"Chiu YH, Ritchlin CT (2012) Biomarkers to diagnose early arthritis in patients with psoriasis. Psoriasis Forum \/ National Psoriasis Foundation 18(2):2\u201310","journal-title":"Psoriasis Forum \/ National Psoriasis Foundation"},{"issue":"12","key":"5132_CR43","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.21873\/anticanres.12107","volume":"37","author":"A Bavelloni","year":"2017","unstructured":"Bavelloni A, Ramazzotti G, Poli A, Piazzi M, Focaccia E, Blalock W, Faenza I (2017) MiRNA-210: a current overview. Anticancer Res 37(12):6511\u20136521. https:\/\/doi.org\/10.21873\/anticanres.12107","journal-title":"Anticancer Res"},{"issue":"61","key":"5132_CR44","doi-asserted-by":"publisher","first-page":"103315","DOI":"10.18632\/oncotarget.21733","volume":"8","author":"F Dias","year":"2017","unstructured":"Dias F, Teixeira AL, Ferreira M, Adem B, Bastos N, Vieira J, Fernandes M, Sequeira MI, Mauricio J, Lobo F, Morais A, Oliveira J, Kok K, Medeiros R (2017) Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma. Oncotarget 8(61):103315\u2013103326. https:\/\/doi.org\/10.18632\/oncotarget.21733","journal-title":"Oncotarget"},{"issue":"5","key":"5132_CR45","first-page":"2940","volume":"11","author":"H Gu","year":"2019","unstructured":"Gu H, Wu L, Chen H, Huang Z, Xu J, Zhou K, Zhang Y, Chen J, Xia J, Yin X (2019) Identification of differentially expressed microRNAs in the bone marrow of osteoporosis patients. Am J Transl Res 11(5):2940\u20132954","journal-title":"Am J Transl Res"},{"issue":"1","key":"5132_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/jnc.13097","volume":"134","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Li L, Tan X, Liu B, Zhang Y, Li C (2015) miR-210 mediates vagus nerve stimulation-induced antioxidant stress and anti-apoptosis reactions following cerebral ischemia\/reperfusion injury in rats. J Neurochem 134(1):173\u2013181. https:\/\/doi.org\/10.1111\/jnc.13097","journal-title":"J Neurochem"},{"issue":"5","key":"5132_CR47","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1513\/AnnalsATS.201412-591OC","volume":"12","author":"JD Jaramillo","year":"2015","unstructured":"Jaramillo JD, Wilson C, Stinson DJ, Lynch DA, Bowler RP, Lutz S, Bon JM, Arnold B, McDonald ML, Washko GR, Wan ES, DeMeo DL, Foreman MG, Soler X, Lindsay SE, Lane NE, Genant HK, Silverman EK, Hokanson JE, Make BJ, Crapo JD, Regan EA (2015) Reduced bone density and vertebral fractures in smokers. Men and COPD patients at increased risk. Ann Am Thorac Soc 12(5):648\u2013656. https:\/\/doi.org\/10.1513\/AnnalsATS.201412-591OC","journal-title":"Ann Am Thorac Soc"},{"key":"5132_CR48","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.clnu.2015.01.003","volume":"34","author":"Y Wada","year":"2015","unstructured":"Wada Y, Hisamatsu T, Naganuma M, Matsuoka K, Okamoto S, Inoue N, Yajima T, Kouyama K, Iwao Y, Ogata H, Hibi T, Abe T, Kanai T (2015) Risk factors for decreased bone mineral density in inflammatory bowel disease: a cross-sectional study. Clin Nutr 34:1202\u20131209. https:\/\/doi.org\/10.1016\/j.clnu.2015.01.003","journal-title":"Clin Nutr"},{"issue":"1","key":"5132_CR49","first-page":"21","volume":"53","author":"EM Farber","year":"1994","unstructured":"Farber EM, Nall L (1994) Psoriasis and alcoholism. Cutis 53(1):21\u201327","journal-title":"Cutis"},{"issue":"4","key":"5132_CR50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2340\/0001555574302304","volume":"74","author":"S Marrakchi","year":"1994","unstructured":"Marrakchi S, Kim I, Delaporte E, Briand G, Degand P, Maibach HI, Thomas P (1994) Vitamin A and E blood levels in erythrodermic and pustular psoriasis associated with chronic alcoholism. Acta Derm Venereol 74(4):298\u2013301","journal-title":"Acta Derm Venereol"},{"issue":"48","key":"5132_CR51","first-page":"1435","volume":"84","author":"A Widmer","year":"1995","unstructured":"Widmer A (1995) A case from practice (337). Psoriasis vulgaris, Hallopeau\u2019s continuous suppurative acrodermatitis. Psoriatic arthropathy. Chronic alcoholism with personality changes, polyneuropathy, hepatopathy. Cardiomyopathy with chronic atrial fibrillation, thrombocytopathy, macrocytosis. Praxis 84(48):1435","journal-title":"Praxis"},{"issue":"1","key":"5132_CR52","first-page":"9","volume":"21","author":"I Dediol","year":"2009","unstructured":"Dediol I, Buljan M, Buljan D, Bulat V, Zivkovic MV, Situm M (2009) Association of psoriasis and alcoholism: psychodermatological issue. Psychiatr Danub 21(1):9\u201313","journal-title":"Psychiatr Danub"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05132-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T12:19:31Z","timestamp":1696162771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05132-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5132"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05132-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"23 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by Chang Gung Memorial Hospital\u2019s Institutional Review Committee on Human Research (Institutional Review Board numbers: 102-4669B and 104-5733B). Informed consent was not obtained from the individual patients in the retrospective part of study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The author read and approved the final manuscript and agrees to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}